Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Cisplatin and Gemcitabine (GC) Variant #34 | — | R 15 338 | 56d | — | ~10.3 mo | — | — | 1 |
Carboplatin and Ifosfamide Variant #01 | — | R 9 909 | 21d | — | — | — | — | — |
Observation Partial | — | — | — | — | — | — | — | 2 |
Radiation therapy N/A - radiation Partial | — | — | 49d | — | — | — | — | 3 |
4 of 4 regimens shown